FDA OKs shingles vaccine
WASHINGTON — Drug maker Merck won federal approval Friday to market the first shingles vaccine to people 60 and older, a potential market of millions as baby boomers age.
The Food and Drug Administration (FDA) said it had cleared the way for Merck to begin shipping the vaccine, Zostavax. The vaccine is only for adults who have had chickenpox
· Read The Full Paralysis Article From Seattle Times -->
·
Read All Paralysis News Stories -->